Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systematic review and meta-analysis

Drug and Alcohol Dependence

Volumn 78, Issue 1, 2005, Pages 1-22

  Torrens, Marta ^a   Fonseca, Francina ^a   Mateu, Gerard ^a   Farré, Magí ^b,c  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Alcohol; Antidepressant; Cocaine; Major depression; Nicotine; Opioid

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; COCAINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; GEPIRONE; IMIPRAMINE; MOCLOBEMIDE; NALTREXONE; NEFAZODONE; NICOTINE; NORTRIPTYLINE; OPIATE; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VILOXAZINE;

ALCOHOLISM; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; DEPRESSION; DRUG EFFICACY; HUMAN; LITERATURE; META ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SUBSTANCE ABUSE; SYSTEMATIC REVIEW;

EID: 14844345498     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.09.004     Document Type: Review

References (130)

1. J.S. Ahluwalia, K.J. Harris, D. Catley, K.S. Okuyemi, and M.S. Mayo Sustained-release bupropion for smoking cessation in African Americans: a randomised controlled trial J. Am. Med. Assoc. 288 2002 468 474
2. A.C. Altamura, M.C. Mauri, T. Girardi, and B. Panetta Alcoholism and depression: a placebo controlled study with viloxazine Int. J. Clin. Pharm. Res. 10 1990 293 298
3. S.M. Angelone, L. Bellini, D. Di Bella, and M. Catalano Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics Alcohol Alcohol 33 1998 151 156
4. I.O. Arndt, L. Dorozynsky, G.E. Woody, A.T. McLellan, and C.P. O'Brien Desipramine treatment of cocaine dependence in methadone-maintained patients Arch. Gen. Psychiatry 49 1992 888 893
5. T.F. Babor, Z. Dolinsky, R.E. Meyer, M. Hesselbrock, M. Hofmann, and H. Tennen Types of alcoholics: concurrent and predictive validity of some common classification schemes Br. J. Addict. 87 1992 1415 1431
6. S.L. Batki, A.M. Washburn, K. Delucchi, and R.T. Jones A controlled trial of fluoxetine in crack cocaine dependence Drug Alcohol Depend. 41 1996 137 142
7. I. Berlin, S. Said, O. Spreux-Varoquaux, J.M. Launay, R. Olivares, V. Millet, Y. Lecubrier, and A. Puech A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers Clin. Pharmacol. Ther. 58 1995 444 452
8. T. Blondal, L.J. Gudmundsson, K. Tomasson, D. Jonsdottir, H. Hilmarsdottir, F. Kristjansson, F. Nilsson, and U.S. Bjornsdottir The effects of fluoxetine combined with nicotine inhalers in smoking cessation - a randomized trial Addiction 94 1999 1007 1013
9. B. Borrelli, B. Spring, R. Niaura, J. Kristeller, J.K. Ockene, and N.J. Keuthen Weight suppression and weight rebound in ex-smokers treated with fluoxetine J. Consult. Clin. Psychol. 67 1999 124 131
10. J.L. Campbell, H.M. Thomas, W. Gabrielli, B.I. Liskow, and B.J. Powell Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings J. Addict. Dis. 13 1994 191 199
11. K.M. Carpenter, A.C. Brooks, S.K. Vosburg, and E.V. Nunes The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial Drug Alcohol Depend. 74 2004 123 134
12. K.M. Carroll, B.J. Rounsaville, L.T. Gordon, C. Nich, P. Jatlow, R.M. Bisighini, and F.H. Gawin Psychotherapy and pharmacotherapy for ambulatory cocaine abusers Arch. Gen. Psychiatry 51 1994 177 187
13. K.N.R. Chengappa, R.K. Kambhampati, K. Perkins, R. Nigam, T. Anderson, J.S. Brar, H.K. Vemulappalli, R. Atzert, P. Key, J.S. Kang, and J. Levine Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants J. Clin. Psychiatry 62 2001 503 508
14. C.R. Cloninger Neurogenetic adaptative mechanisms in alcoholism Science 236 1987 410 416
15. J.R. Cornelius, I.M. Salloum, M.D. Cornelius, J.M. Perel, J.G. Ehler, P.J. Jarrett, P.L. Levin, A. Black, and J.J. Mann Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics Psychopharmacol. Bull. 31 1995 297 303
16. J.R. Cornelius, I.M. Salloum, J.G. Ehler, P.J. Jarret, M.D. Cornelius, J.M. Perel, M.E. Thase, and A. Black Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial Arch. Gen. Psychiatry 54 1997 700 705
17. J.R. Cornelius, I.M. Salloum, M.E. Thase, R.F. Haskett, D.C. Daley, A. Jones-Barlock, C. Upsher, and J.M. Perel Fluoxetine versus placebo in depressed alcoholic cocaine abusers Psychopharmacol. Bull. 34 1998 117 121
18. J.R. Cornelius, I.M. Salloum, R.F. Haskett, D.C. Daley, M.D. Cornelius, M.E. Thase, and J.M. Perel Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study Addict. Behav. 25 2000 307 310
19. J.W. Cornish, I. Maany, P.J. Fudala, R.N. Ehrman, S.J. Robbins, and C.P. O'Brien A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence Drug Alcohol Depend. 61 2001 183 189
20. L.S. Covey, A.H. Glassman, F. Stetner, S. Rvelli, and K. Stage A randomized trial of sertraline as a cessation aid for smokers with a history of major depression Am. J. Psychiatry 159 2002 1731 1737
21. L. Covi, J.M. Hess, N.A. Kreitner, and C.A. Haertzen Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers Am. J. Drug Alcohol Abuse 21 1995 327 344
22. C.L. Da Costa, R.N. Younes, and M.T. Lourenco Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo Chest 122 2002 403 408
23. L.C. Dale, E.D. Glover, D.P. Sachs, D.R. Schoreder, K.P. Offord, I.T. Croghan, and R.D. Hurt Bupropion for smoking cessation: predictors of succesful outcome Chest 119 2001 1357 1364
24. L.C. Dale, J.O. Ebbert, D.R. Schroeder, I.T. Croghan, D.F. Rasmussen, J.A. Trautman, L.S. Cox, and R.D. Hurt Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study Nicotine Tob. Res. 4 2002 267 274
25. A.J. Dean, J. Bell, D.J. Mascord, G. Parker, and M.J. Christie A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms J. Affective Disorders 72 2002 85 90
26. M.J. Durcan, J. White, D.E. Jorenby, M.C. Fiore, S.I. Rennard, S.J. Leischow, M.A. Nides, J.A. Ascher, and J.A. Johnston Impact of prior nicotine replacement therapy on smoking cessation efficacy Am. J. Health Behav. 26 2002 213 220
27. N.B. Edwards, J.K. Murphy, A.D. Downs, B.J. Ackerman, and T.L. Rosenthal Doxepine as an adjunt to smoking cessation: a double-blind pilot study Am. J. Psychiatry 146 1989 373 376
28. A.E. Evins, V.K. Mays, N.A. Rigotti, T. Tisdale, C. Cather, and D.C. Goff A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia Nicotine Tob. Res. 3 2001 397 403
29. A. Feingold, A. Oliveto, R. Schottenfeld, and T.R. Kosten Utility of crossover designs in clinical trials: eficacy of desipramine vs. placebo in opioid dependent cocaine abusers Am. J. Addict. 11 2002 11 23
30. Fiore, M.C., Bailey, W.C., Cohen, S.J., et al., 2000. Treating tobacco use and dependence, in: Clinical Practice Guideline. US Department of Health and Human Services, Rockville (MD). Public Health Service, Jun.
31. J.C. Garbutt, S.L. West, T.S. Carey, K.N. Lohr, and F.T. Crews Pharmacological treatment of alcohol dependence. A review of the evidence J. Am. Med. Assoc. 281 1999 1318 1325
32. F.H. Gawin, and E.H. Ellinwood Cocaine and other stimulants: actions, abuse and treatments N. Engl. J. Med. 318 1988 1173 1182
33. F.H. Gawin, H.D. Kleber, R. Byck, B.J. Rounsaville, T.R. Kosten, P.I. Jatlow, and C. Morgan Desipramine facilitation of initial cocaine abstinence Arch. Gen. Psychiatry 46 1989 117 126
34. T.P. George, J.C. Vessicchio, A. Termine, T.A. Bregartner, A. Feingold, B.J. Rounsaville, and T.R. Kosten A placebo controlled trial of bupropion for smoking cessation in schizophrenia Biol. Psychiatry 52 2002 53 61
35. G. Gerra, R. Caccavari, R. Delsignore, R. Bocchi, G. Fertonani, and M. Passeri Effects of fluoxetine and Ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcohol patients Curr. Ther. Res. 52 1992 291 295
36. J. Giannini, R.H. Loiselle, and M.C. Giannini Space-based abstinence: allevation of withdrawal symptoms in combinative cocaine-phencyclidine abuse J. Clin. Toxicol. 25 1987 493 500
37. A.H. Glassman, F. Stetner, B.T. Walsh, P.S. Raizman, J.L. Fleiss, T.B. Cooper, and L.S. Covey Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial J. Am. Med. Assoc. 259 1988 2863 2866
38. E.D. Glover, P.N. Glover, C.R. Sullivan, C.L. Cerullo, and G. Hobbs A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation Am. J. Health Behav. 26 2002 386 393
39. D.H. Gonzales, M.A. Nides, L.H. Ferry, R.P. Kustra, B.D. Jamerson, N. Segall, L.A. Herrero, A. Krishen, and B.A. Sweeney Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study Clin. Pharmacol. Ther. 69 2001 438 444
40. G. Gonzalez, A. Feingold, A. Oliveto, K. Gonsai, and T.R. Kosten Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management Am. J. Drug Alcohol Abuse 29 2003 497 514
41. D.A. Gorelick, and A. Paredes Effect of fluoxetine on alcohol consumption in male alcoholics Alcohol Clin. Exp. Res. 16 1992 261 265
42. B. Grant, and T.C. Harford Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey Drug Alcohol Depend. 39 1995 197 206
43. J. Grabowski, H. Rhoades, R. Elk, J. Schmitz, C. Davis, D. Creson, and K. Kirby Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo controlled double-blind trials J. Clin. Psychopharmacol. 15 1995 163 174
44. A. Gual, M. Balcells, M. Torres, M. Madrigal, T. Diez, and L. Serrano Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial Alcohol Alcohol. 38 2003 619 625
45. S.M. Hall, S. Tunis, E. Triffleman, P. Banys, H.W. Clark, D. Tusel, P. Stewart, and D. Presti Continuity of care and desipramine in primary cocaine abusers J. Nerv. Ment. Dis. 182 1994 570 575
46. S.M. Hall, V.I. Reus, R.F. Munoz, K.L. Sees, G. Humfleet, D.T. Hartz, S. Frederick, and E. Triffleman Nortryptiline and cognitive-behavioral therapy in the treatment of cigarette smoking Arch. Gen. Psychiatry 55 1998 683 690
47. S.M. Hall, G. Humfleet, V.I. Reus, R.F. Munoz, D.T. Hartz, and R. Maude-Griffin Psychological intervention and antidepressant treatment in smoking cessation Arch. Gen. Psychiatry 59 2002 930 936
48. Hasin, D., Trautman, K., Miele, G., Endicott, J. 1995. Psychiatric research interview of substance and mental disorders (PRISM).
49. D.S. Hasin, and E.V. Nunes Comorbidity of alcohol, drug, and psychiatric disorders, epidemiology H.R. Kranzler B.J. Rounsaville Dual Diagnosis and Treatment 1998 Marcel Dekker Inc. New York 1 30
50. D. Hasin, X. Liu, E. Nunes, S. McCloud, S. Samet, and J. Endicott Effects of major depression on remission and relapse of substance dependence Arch. Gen. Psychiatry 59 2002 375 380
51. J.T. Hays, R.D. Hurt, N.A. Rigotti, R. Niaura, D. Gonzales, M.J. Durcan, D.P.L. Sachs, T.D. Wolter, A.S. Buist, J.A. Johnston, and J.D. White Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial Ann. Int. Med. 135 2001 423 433
52. S.H. Heil, G.J. Badger, and S.T. Higgins Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics J. Stud. Alcohol. 62 2001 14 22
53. M.A. Hertzberg, S.D. Moore, M.E. Feldman, and J.C. Beckman A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder J. Clin. Psychopharmacol. 21 2001 94 98
54. B. Hitsman, R. Pingitore, B. Spring, A. Mahableshwarka, J.S. Mizes, K.A. Segraves, J.L. Kristeller, and W. Xu Antidepressant pharmacotherapy helps some cigarette smokers more than others J. Consult. Clin. Psychol. 67 1999 547 554
55. B. Hitsman, B. Spring, B. Borrelli, R. Niaura, and G.D. Papandonatos Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine Exp. Clin. Psychopharmacol. 9 2001 355 362
56. B. Hitsman, B. Borrelli, D.E. McChargue, B. Spring, and R. Niaura History of depression and smoking cessation outcome: a meta-analysis, 2003 J. Consult. Clin. Psychol. 71 2003 657 663
57. Hughes, J.R., Stead, L.F., Lancaster, T. 2003. Antidepressants for smoking cessation. The Cochrane Library. 1.
58. R.D. Hurt, D.P.L. Sachs, E.D. Glover, K.P. Offord, J.A. Johnston, L.C. Dale, M.A. Khayrallah, D.R. Schoroeder, P.N. Glover, C.R. Sullivan, I.T. Croghan, and P.M. Sullivan A comparison of sustained-release bupropion and placebo for smoking cessation N. Engl. J. Med. 337 1997 1195 1202
59. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, and H.J. McQuay Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin. Trials 17 1996 1 12
60. B.D. Jamerson, M. Nides, D.E. Jorenby, R. Donahue, P. Garrett, J.A. Johnston, M.C. Fiore, S.I. Rennard, and S.J. Leischow Late-term smoking cessation despite initial failure: An evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo Clin. Ther. 23 2001 744 752
61. L. Janiri, G. Gobbi, P. Mannelli, G. Pozzi, A. Serretti, and E. Tempesta Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics Int. Clin. Psychopharmacol. 11 1996 109 117
62. S.W. Jenkins, N.A. Warfield, J.K. Blaine, J. Cornish, W. Ling, M.I. Rosen, H. Urschel, D. Wesson, and D. Ziedonis A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency Psychaopharmacol. Bull. 28 1992 21 26
63. J.A. Johnston, J. Fiedler-Kelly, E.D. Glover, D.P.L. Sachs, T.H. Grasela, and J. De Veaugh-Geiss Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation Nicotine Tob. Res. 3 2001 131 140
64. D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J. Johnston, A.R. Hughes, S.S. Smith, M.L. Muramoto, K.M. Daughton, K. Doan, M.C. Fiore, and T.B. Baker A Controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation N. Engl. J. Med. 340 1999 685 691
65. D.I. Kabel, and F. Petty A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence Alcohol. Clin. Exp. Res. 20 1996 780 784
66. R. Kessler, K. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eshleman, H.U. Wittchen, and K.S. Kendler Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey Arch. Gen. Psychiatry 51 1994 8 19
67. J.D. Killen, S.P. Fortmann, A.F. Schatzberg, C. Hayward, L. Sussman, M. Rothman, L. Strausberg, and A. Varady Nicotine patch and paroxetine for smoking cessation J. Consult. Clin. Psychol. 68 2000 883 889
68. J.D. Killen, S.P. Fortmann, A. Schatzberg, C. Hayward, and A. Varady Onset of major depression during treatment for nicotine dependence Addict. Behav. 28 2003 461 470
69. H.D. Kleber, M.M. Weissman, B.J. Rounsaville, C.H. Wilber, B.A. Prusoff, and C.E. Riordan Imipramine as treatment for depression in addicts Arch. Gen. Psychiatry 40 1983 649 653
70. P.H. Kleinman, A.B. Miller, R.B. Millman, G.E. Woody, T. Todd, J. Kemp, and D.S. Lipton Psychopathology among cocaine abusers entering treatment J. Nerv. Ment. Dis. 178 1990 442 447
71. A.F. Kolar, B.S. Brown, W.W. Weddington, C.C. Haertzen, B.S. Michaelson, and J.H. Jaffe Treatment of Cocaine Dependence in Methadone Maintenance Clients: a pilot study comparing the efficacy of desipramine and amantadine Int. J. Addict. 27 1992 849 868
72. T.R. Kosten, C.M. Morgan, J. Falcione, and R.S. Schottenfeld Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine Arch. Gen. Psychiatry 49 1992 894 898
73. T. Kosten, A. Oliveto, A. Feingold, J. Poling, K. Sevarino, E. McCance-Katz, S. Stine, G. Gonzalez, and K. Gonsai Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients Drug Alcohol Depend. 70 2003 315 325
74. H.R. Kranzler, J.A. Burleson, P. Korner, F.K. Del Boca, M.J. Bohn, J. Brown, and N. Liebowitz Placebo-controlled trial of fluoxetine as an adjunt to relapse prevention in alcoholics Am. J. Psychiatry 152 1995 391 397
75. H.R. Kranzler, J.A. Burleson, J. Brown, and T.F. Babor Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics Alcohol Clin. Exp. Res. 20 1996 1534 1541
76. H.R. Kranzler, and B.J. Rounsaville Dual Diagnosis and Treatment 1998 Marcel Dekker New York
77. H.R. Kranzler, V. Modesto-Lowe, and J. Van Kirk Naltrexone vs. Nefazodone for treatment of alcohol dependence Neuropsychopharmacology 22 2000 493 503
78. E.M. Krupitsky, A.M. Burakov, V.B. Ivanov, G.F. Krandashova, I.P. Lapin, A.J. Grinenko, and Yu.S. Borodkin Baclofen administration for the treatment of affective disorders in alcoholic patients Drug Alcohol Depend. 33 1993 157 163
79. C. Lerman, D. Roth, V. Kaufmann, J. Aurain, L. Hawk, L. Aiyi, R. Niaura, and L. Epstein Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug Alcohol Depend. 67 2002 219 223
80. M.S. Lima, B.G. de Oliveira Soares, A.A. Reisser, and M. Farrell Pharmacological treatment of cocaine dependence: a systematic review Addiction 97 2002 931 949
81. M.S. Lima, A.A. Reisser, B.G. Soares, and M. Farrell Antidepressants for cocaine dependence Cochrane Database Syst. Rev. 2 2003 CD002950
82. A. Margolin, T.R. Kosten, S.K. Avants, J. Wilkins, W. Ling, M. Beckson, I.O. Arndt, J. Cornish, J.A. Ascher, S.H. Li, and P. Brige A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients Drug Alcohol Depend. 40 1995 125 131
83. T.L. Mark, H.R. Kranzler, X. Song, P. Bransberger, V.H. Poole, and S. Crosse Physicians' opinions about medications to treat alcoholism Addiction 98 2003 617 626
84. B.J. Mason, and J.H. Kocsis Desipramine treatment of alcoholism Psychopharmacol. Bull. 27 1991 155 161
85. B.J. Mason, J.H. Kocsis, E.C. Ritvo, and R.B. Cutler A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence and stratified on the presence or absence of major depression J. Am. Med. Assoc. 275 1996 803 804
86. L.S. McElroy, R.D. Weiss, J.H. Mendelson, S.K. Teoh, B. McAfee, and N.K. Mello Desipramine treatment for relapse prevention in cocaine dependence NIDA Res. Monogr. 95 1989 57 63
87. P.J. McGrath, E.V. Nunes, J.W. Stewart, D. Goldman, V. Agosti, K. Ocepek-Velikson, and F.M. Quitkin Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial Arch. Gen. Psychiatry 53 1996 232 240
88. P.J. McGrath, E.V. Nunes, and F.M. Quitkin Current concepts in the treatment of depression in alcohol-dependent patients Psychiatr. Clin. North Am. 23 2000 695 711
89. D.H. Moak, R.F. Anton, P.K. Latham, K.E. Voronin, R.L. Waid, and R. Durazo-Arvizu Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial J. Clin. Psychopharmacol. 23 2003 553 562
90. C.A. Naranjo, C.X. Poulos, K.E. Bremmer, and K.L. Lanctôt Citalopram decreases desirability, liking and consumption of alcohol-dependent drinkers Clin. Pharmacol. Ther. 51 1992 729 739
91. C.A. Naranjo, C.X. Poulos, K.E. Bremmer, and K.L. Lanctôt Fluoxetine attenuates alcohol intake and desire to drink Int. Clin. Psychopharmacol. 9 1994 163 172
92. C.C. Naranjo, K.E. Bremmner, and K.L. Lanctôt Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems Addiction 90 1995 87 99
93. C.A. Naranjo, and D.M. Knoke The role of selective reuptake inhibitors in reducing alcohol consumption J. Clin. Psychiatry 62 Suppl. 20 2001 18 25
94. R. Niaura, B. Spring, B. Borrelli, D. Hedeker, M.G. Goldstein, N. Keuthen, J. De Pue, J. Kristeller, J. Ockene, A. Prochazka, J.A. Chiles, and D.B. Abrams Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment J. Consult. Clin. Psychol. 70 2002 887 896
95. E.V. Nunes, P.J. McGrath, F.M. Quitkin, J.P. Stewart, W. Harrison, E. Tricamo, and K. Ocepek-Welikson Imipramine treatment of alcoholism with comorbid depression Am. J. Psychiatry 150 1993 963 965
96. E.V. Nunes, S.J. Donovan, R. Brady, and F.M. Quitkin Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients J. Psychoactive Drugs 26 1994 147 153
97. E.V. Nunes, P.J. McGrath, F.M. Quitkin, K. Ocepek-Welikson, J.W. Stewart, T. Koeng, S. Wager, and D.F. Klein Imipramine treatment of cocaine abuse: possible boundaries of efficacy Drug Alcohol Depend. 39 1995 185 195
98. E.V. Nunes, F.M. Quitkin, S.J. Donovan, D. Deliyannides, K. Ocepek-Welikson, T. Koeng, R. Brady, P.J. McGrath, and G. Woody Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial Arch. Gen. Psychiatry 55 1998 153 160
99. E.V. Nunes, and F.R. Levin Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis J. Am. Med. Assoc. 29 2004 1887 1896
100. C.P. O'Brien, A.R. Childress, I.O. Arndt, A.T. McLellan, G.E. Woody, and I. Maany Pharmacological and behavioral treatments of cocaine dependence: controlled studies J. Clin. Psychiatry 49 Suppl. 1988 17 22
101. I. Petrakis, K.M. Carroll, C. Nich, L. Gordon, T. Kosten, and B. Rounsaville Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts Drug Alcohol Depend. 50 1998 221 226
102. H.M. Pettinati The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes J. Clin. Psychiatry 62 Suppl. 20 2001 26 31
103. H.M. Pettinati, J.R. Volpicelli, H.R. Kranzler, G. Luck, M.R. Rukstalis, and A. Cnaan Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype Alcohol Clin. Exp. Res. 24 2000 1041 1049
104. H.M. Pettinati, J.R. Volpicelli, G. Luck, H.R. Kranzler, M.R. Rukstalis, and A. Cnaan Double-blind clinical trial of sertraline treatment for alcohol dependence J. Clin. Psychopharmacol. 21 2001 143 153
105. H.M. Pettinati, H.R. Kranzler, and J. Madaras The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence Recent Dev. Alcohol 16 2003 247 262
106. B.J. Powell, J.L. Campbell, J.F. Landon, B.I. Liskow, H.M. Thomas, E.J. Nickel, T.M. Dale, E.C. Penick, S.D. Samuelson, and R.B. Lacoursiere Alcohol Clin. Exp. Res. 19 1995 462 468
107. A.V. Prochazka, M.J. Weaver, R.T. Keller, G.E. Fryer, P.A. Licari, and D. Lofaso A randomized trial of nortriptyline for smoking cessation Arch. Intern. Med. 158 1998 2035 2039
108. E.B. Raimo, T.L. Smith, G.P. Danko, K.K. Bucholz, and M.A. Schuckit Clinical characteristics and family histories of alcoholics with stimulant dependence J. Stud. Alcohol 61 2000 728 735
109. D.A. Regier, M.E. Farmer, D.S. Rae, B. Locke, S. Keith, L. Judd, and F. Goodwin Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study J. Am. Med. Assoc. 264 1990 2511 2518
110. B.J. Rounsaville, M. Weissman, K. Crits-Christoph, C. Wilber, and H. Kleber Diagnosis and symptoms of depression in opiate addicts; course and relationship to treatment outcome Arch. Gen. Psychiatry 39 1982 151 156
111. B. Rounsaville, Z. Dolinsky, T. Babor, and R. Meyer Psychopathology as a predictor of treatment outcome in alcoholics Arch. Gen. Psychiatry 44 1987 505 513
112. B.J. Rounsaville, S.F. Anton, K. Carroll, D. Budde, B.A. Prussof, and F. Gawin Psychiatric diagnoses of treatment-seeking cocaine abusers Arch. Gen. Psychiatry 48 1991 43 51
113. A. Roy Placebo-controlled study of sertraline in depressed recently abstinent alcoholics Biol. Psychiatry 44 1998 633 637
114. P.P. Roy-Byrne, K.P. Pages, J.E. Russo, C. Jaffe, A.W. Blume, E. Kingsley, D.S. Cowley, and R.K. Ries Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial J. Clin. Psychopharmacol. 20 2000 129 136
115. S.S. Smith, D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, B. Jamerson, M.C. Fiore, and T.B. Baker Targeting smokers at increased risk for relapse: treating women and those with a history of depression Nicotine Tob. Res. 5 2003 99 109
116. J.M. Schmitz, A.L. Stotts, P.M. Averill, J.M. Rothfleisch, S.E. Bailley, S.L. Sayre, and J. Grabowski Cocaine dependence with and without comorbid depression: a comparison of patient characteristics Drug Alcohol Depend. 60 2000 189 198
117. J.M. Schmitz, P. Averill, A.L. Stotts, F.G. Moeller, H.M. Rhoades, and J. Grabowski Fluoxetine treatment of cocaine-dependent patients with major depressive disorder Drug Alcohol Depend. 63 2001 207 214
118. M.A. Sullivan, and L.S. Covey Nicotine dependence: the role for antidepressants and anxiolytics Curr. Opin. Invest. Drug 3 2002 262 271
119. D.P. Tashkin, R. Kanner, W. Bailey, S. Buist, P. Anderson, M.A. Nides, D. Gonzales, G. Dozier, M.K. Patel, and B.D. Jamerson Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial Lancet 357 2001 1571 1575
120. F.S. Tennant, and A.L. Tarver Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence NIDA Res. Monogr. 55 1984 159 163
121. M.E. Thase, I.M. Salloum, and J.D. Cornelius Comorbid alcoholism and depression: treatment issues J. Clin. Psychiatry 62 Suppl. 20 2001 32 41
122. J. Tiihonen, O.-P. Ryynänen, J. Kauhanen, H.P.A. Hakola, and M. Salaspuro Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study Pharmacopsychiatry 29 1996 27 29
123. J. Titievsky, G. Seco, M. Barranco, and E.M. Kyle Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study J. Clin. Psychiatry 43 1982 454 456
124. M. Torrens, D. Serrano, M. Astals, G. Pérez-Domínguez, and R. Martín-Santos Diagnosing psychiatric comorbidity in substance abusers. Validity of the spanish versions of psychiatric research interview for substance and mental disorders (PRISM-IV) and the structured clinical interview for DSM-IV (SCID-IV) Am. J. Psychiatry 161 2004 1231 1237
125. J. Uslaner, A. Kalechstein, T. Richter, W. Ling, and T. Newton Association of depressive symptoms during abstinence with the subjective high produced by cocaine Am. J. Psychiatry 56 1999 1444 1446
126. W.W. Weddington, B.S. Brown, C.A. Haerzen, J.M. Hess, J.R. Mahaffey, A.F. Kolar, and J.H. Jaffe Comparison of amantadine combined with psychotherapy for treatment of cocaine dependence Am. J. Drug Alcohol Abuse 17 1991 137 152
127. R.D. Weiss, S.M. Mirin, and J.L. Michael Psychopathology in chronic cocaine abusers Am. J. Drug Alcohol Abuse 12 1986 17 29
128. R. West, A. McNeill, and M. Raw Smoking cessation guidelines for health professionals: an update Thorax 55 2000 987 999
129. G.E. Woody, C.P. O'Brien, and K. Rickels Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone Am. J. Psychiatry 132 1975 447 450
130. D.M. Ziedonis, and T.R. Kosten Depression as a prognostic factor for pharmacological treatment of cocaine dependence Psychopharmacol. Bull. 27 1991 337 343